{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:54:53Z","timestamp":1774317293163,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.prp.2019.152607","type":"journal-article","created":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T01:11:31Z","timestamp":1566695491000},"page":"152607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Apolipoprotein E is a predictive marker for assessing non-small cell lung cancer patients with lymph node metastasis"],"prefix":"10.1016","volume":"215","author":[{"given":"Hyo Jung","family":"An","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Min","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Hyun","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2019.152607_bib0005","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/ejcts\/ezw040","article-title":"Management of stage IIIA (N2) non-small-cell lung cancer: a transatlantic perspective","volume":"49","author":"Rocco","year":"2016","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.prp.2019.152607_bib0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12944-016-0288-2","article-title":"APOE genotype and stress response a mini review","volume":"15","author":"Dose","year":"2016","journal-title":"Lipids Health Dis."},{"issue":"4","key":"10.1016\/j.prp.2019.152607_bib0015","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1172\/JCI200519935","article-title":"Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts","volume":"115","author":"Zhuang","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2019.152607_bib0020","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.arcmed.2008.06.009","article-title":"Increased apolipoprotein E gene expression and protein concentration in lung cancer tissue do not contribute to the clinical assessment of non-small cell lung cancer patients","volume":"39","author":"Trost","year":"2008","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.prp.2019.152607_bib0025","doi-asserted-by":"crossref","first-page":"10715","DOI":"10.1007\/s13277-016-4975-4","article-title":"Elevated serum apolipoprotein E is associated with metastasis and poor prognosis of non-small cell lung cancer","volume":"37","author":"Luo","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.prp.2019.152607_bib0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.lungcan.2010.04.009","article-title":"Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer","volume":"71","author":"Su","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prp.2019.152607_bib0035","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.4049\/jimmunol.1403215","article-title":"Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor t cell responses in the lungs","volume":"194","author":"Sharma","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.prp.2019.152607_bib0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.prp.2019.152607_bib0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1158\/0008-5472.331.65.1","article-title":"Apolipoprotein e is required for cell proliferation and survival in ovarian cancer","volume":"65","author":"Chen","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2019.152607_bib0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature07203","article-title":"From endoplasmic-reticulum stress to the inflammatory response","volume":"454","author":"Zhang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.prp.2019.152607_bib0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1353\/hpu.2014.0009","article-title":"Apolipoprotein E4 prevents growth of malaria at the intraerythrocyte stage: implications for differences in racial susceptibility to Alzheimer\u2019s disease","volume":"24","author":"Fujioka","year":"2003","journal-title":"J. Health Care Poor Underserv."},{"key":"10.1016\/j.prp.2019.152607_bib0060","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/jhep.2002.34745","article-title":"Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus","volume":"36","author":"Wozniak","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.prp.2019.152607_bib0065","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/jmg.40.5.348","article-title":"Does apolipoprotein E polymorphism influence susceptibility to malaria?","volume":"40","author":"Wozniak","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.prp.2019.152607_bib0070","doi-asserted-by":"crossref","first-page":"e102477","DOI":"10.1371\/journal.pone.0102477","article-title":"Apolipoprotein e polymorphism and colorectal neoplasm: results from a meta-analysis","volume":"9","author":"Tian","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2019.152607_bib0075","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3389\/fgene.2018.00650","article-title":"Apolipoprotein e overexpression is associated with tumor progression and poor survival in colorectal cancer","volume":"9","author":"Zhao","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.prp.2019.152607_bib0080","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2217\/nnm.13.35","article-title":"ApoE enhances nanodisk-mediated curcumin delivery to glioblastoma multiforme cells","volume":"9","author":"Ghosh","year":"2014","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.prp.2019.152607_bib0085","doi-asserted-by":"crossref","first-page":"19930","DOI":"10.1038\/srep19930","article-title":"Apolipoprotein E epsilon 2 allele and low serum cholesterol as risk factors for gastric cancer in a Chinese Han population","volume":"6","author":"Kang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2019.152607_bib0090","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000107112","article-title":"Apolipoprotein e expression in anaplastic thyroid carcinoma","volume":"71","author":"Ito","year":"2006","journal-title":"Oncology"},{"key":"10.1016\/j.prp.2019.152607_bib0095","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3349\/ymj.2016.57.3.549","article-title":"Apolipoproteins as differentiating and predictive markers for assessing clinical outcomes in patients with small cell lung cancer","volume":"57","author":"Shi","year":"2016","journal-title":"Yonsei Med. J."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819311410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819311410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:38:31Z","timestamp":1759732711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033819311410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0344033819311410"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2019.152607","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein E is a predictive marker for assessing non-small cell lung cancer patients with lymph node metastasis","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2019.152607","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152607"}}